Cell-based therapy for heart failure: skeletal myoblasts.
about
An in silico prediction tool for the expansion culture of human skeletal muscle myoblastsCharacterisation of nuclear architectural alterations during in vitro differentiation of human stem cells of myogenic origin.Isolation of myogenic stem cells from cultures of cryopreserved human skeletal muscle.External physical and biochemical stimulation to enhance skeletal muscle bioengineeringCardiac regenerationImplantation of autologous muscle-derived stem cells in treatment of fecal incontinence: results of an experimental pilot study.Long-term follow-up after autologous skeletal myoblast transplantation in ischaemic heart disease.Experience from experimental cell transplantation therapy of myocardial infarction: what have we learned?Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiologyBcl-2 expression enhances myoblast sheet transplantation therapy for acute myocardial infarction.Stem cell research in cell transplantation: sources, geopolitical influence, and transplantation.In vitro evaluation of gel-encapsulated adipose derived stem cells: Biochemical cues for in vivo peripheral nerve repair.Exogenous connexin43-expressing autologous skeletal myoblasts ameliorate mechanical function and electrical activity of the rabbit heart after experimental infarction.Injected Human Muscle Precursor Cells Overexpressing PGC-1α Enhance Functional Muscle Regeneration after Trauma.Trichostatin a promotes cardiomyocyte differentiation of rat mesenchymal stem cells after 5-azacytidine induction or during coculture with neonatal cardiomyocytes via a mechanism independent of histone deacetylase inhibition.Muscle Precursor Cells for the Restoration of Irreversibly Damaged Sphincter Function
P2860
Q28596285-4109C534-3426-4900-A4F3-F4A794C67291Q31137441-B52E8E9D-C3AB-460C-B364-68E26B87C462Q35167152-EE2504F0-1532-4EE3-968C-183FE9BBFBACQ35469352-939D733D-043C-47E0-BC0F-DC187B7FF89FQ35928368-556A20FE-722D-401B-B01D-A161B44AE0DCQ36244994-96076763-ECFD-4497-BA40-9F2374A03B2AQ37401213-086D19C1-BF8F-4EC9-9986-5682F7C6D739Q38001505-3FE005B0-E5BC-4BF5-86B0-7EC7F1789E2EQ38982831-76674667-A723-458F-A6C7-8CABA22B80CBQ39749909-62D6D487-89CA-4F1F-A336-2C9B088DDF40Q44329785-EC7B4AA5-53E5-4770-A5F8-6CA7F56712B9Q48361619-197C9D00-9CAF-4A37-8A37-CB1D00DE2185Q48692636-ECF2F4B3-90B3-4761-A228-D7642A6624B2Q52659347-AE058C54-B8B5-4787-BC1D-00E95A624628Q53217325-8F6F54AD-82F1-4C64-AA41-F4B22C3D0167Q57395895-5646E9FD-953F-477B-B333-AF7FCAF2AAF9
P2860
Cell-based therapy for heart failure: skeletal myoblasts.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cell-based therapy for heart failure: skeletal myoblasts.
@en
Cell-based therapy for heart failure: skeletal myoblasts.
@nl
type
label
Cell-based therapy for heart failure: skeletal myoblasts.
@en
Cell-based therapy for heart failure: skeletal myoblasts.
@nl
prefLabel
Cell-based therapy for heart failure: skeletal myoblasts.
@en
Cell-based therapy for heart failure: skeletal myoblasts.
@nl
P2093
P2860
P356
P1433
P1476
Cell-based therapy for heart failure: skeletal myoblasts
@en
P2093
Aleksandra Borczyńska
Monika Seidel
Natalia Rozwadowska
P2860
P304
P356
10.3727/096368909X470810
P577
2009-04-06T00:00:00Z